Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

4

SEC Filing Details

Document Details

Form
Filing Date
Jun 20, 2017
Document Date
Jun 18, 2017
Form Description

Statement of changes in beneficial ownership of securities

Filing Group
3,4,5
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved